Latest California Healthline Stories
Gov. Jerry Brown signed many critical health care bills sent to him by the state legislature, cementing California’s role as a health care champion.
Gov. Jerry Brown signed the measure, which takes effect next year and will require drug companies to publicly justify big price increases.
“If it gets signed by this governor, it’s going to send shock waves throughout the country,” one legislator says. Pharma has spent $16.8 million to lobbying against this bill and other drug laws in California.
El tratamiento con una droga aprobada por la Administración de Drogas y Alimentos cuesta menos y cura la hepatitis C en alrededor de dos meses. Pacientes vulnerables tendrían más acceso a esta terapia.
The drug, sold under the name Mavyret, can cure all six genetic types of the liver disease in eight weeks at a cost of $26,400, well below other options.
At a political rally in March, President Donald Trump said drug prices are “outrageous” and blamed campaign contributions. Drugmakers funneled nearly $280,000 to Congress the very next day.
Any momentum to address prescription drug costs has been lost amid rancorous debates over replacing Obamacare and stalled by roadblocks erected via lobbying and industry cash.
The company’s drug spending prediction, far above other insurers in the individual market, has experts scratching their heads. Anthem cites market volatility.
California lawmakers adopted a drug price transparency bill and several other key health care measures as their legislative session ended last week, but they pushed off decisions on some big-name proposals such as single-payer health care.
The proposal, which is headed to the desk of Gov. Jerry Brown, would impose new reporting requirements on drugmakers and health plans but wouldn’t have the power to bring down prices directly.